|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
Nuclea Biotechnologies Lands $554,850 New Funding Round
|
VentureDeal |
05/03/12 |
Boston
|
|
Pervasis, Flagship, SeventhSense, & More Boston Life Sciences Newsmakers
|
Erin Kutz |
04/13/12 |
Boston
|
|
Nuclea Biotechnologies Receives $1,931,700 New Financing
|
VentureDeal |
04/12/12 |
Boston
|
|
Nuclea Biotechnologies Obtains $3,000,000 New Round
|
VentureDeal |
10/11/11 |
Boston
|
|
HubSpot Buys OneForty, Cambridge Diagnostics Startups Nab Funding, Hopper Closes $8M, & More Boston-Area Deals News
|
Erin Kutz |
08/24/11 |
Boston
|
|
Nuclea Biotechnologies Receives $3,000,000 New Funding
|
VentureDeal |
08/19/11 |
Boston
|
|
Nuclea Biotechnologies Obtains $5,479,450 New Round
|
VentureDeal |
11/02/10 |
Boston
|
|
European Regulators Question Antigenics and Biogen Idec Drugs, BioAssets Bags $30M in Option Deal, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
10/28/09 |
Boston
|
|
HubSpot Spots $16M, Synageva BioPharma Secures $12M, Currensee Sews Up $6M, & More Boston-Area Deals News
|
Rebecca Zacks |
10/23/09 |
Boston
|
|
Nuclea Nabs $3.4M Deal
|
Luke Timmerman |
10/22/09 |
Boston
|
|
Nuclea Biotechnologies Lands $3,400,000 New Funding
|
VentureDeal |
10/22/09 |
Boston
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.
